The Bull Rankings scorecard — our quality-growth score is 69.6 / 100, built from three pillars scored 0–100: Quality 71, Growth 75, Value 63 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 6% a year next year, fading to 3% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
Our model assigns a 69.6/100 quality‑growth score, with Growth 75 eclipsing Value 63 and Quality 71.
The model’s Buying back stock signal reinforces the idea that management believes the shares are undervalued relative to the cash‑generating capacity of the firm. If the market had priced in the same growth trajectory, the price would be higher. Therefore, the thesis is that HQY is trading below the value implied by its cash‑flow generation and growth prospects.
What the business actually is
HealthEquity is a technology‑enabled platform that serves both consumers and employers across the United States. Its core offerings include Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). The company also runs an online‑only automated investment advisory service called Advisor, a web‑based tool that manages the investment side of HSAs. In addition, it administers pre‑tax commuter benefit programs and provides a marketplace that gives HSA and FSA members access to specific healthcare products, programs, and services. The revenue engine is driven by the volume of accounts it manages and the transaction fees and investment management fees associated with those accounts.
Why it can (or can't) keep compounding
Margins sit at 17.4 %, a healthy level for a platform that relies on software and automation rather than high‑cost labor. The company’s ROE of 11.9 % indicates that it is turning equity into profit efficiently. The debt‑to‑equity of 0.49 shows a modest leverage profile, allowing room for further investment or share buybacks without over‑extending.
The moat is two‑fold. First, the platform’s technology stack—particularly the Advisor tool—creates a frictionless experience that locks in consumers and employers. Second, the marketplace adds value by bundling ancillary services, increasing customer stickiness. Competitors would need to replicate both the software infrastructure and the network of partners that deliver the marketplace benefits, a time‑consuming and capital‑intensive endeavor.
The Buying back stock signal is the strongest evidence that management believes the shares are undervalued and that the company can sustain or accelerate growth without diluting shareholders.
The valuation question
The PEG ratio of 1.4 says the multiple runs a bit ahead of the earnings growth analysts expect.
The reverse‑DCF view shows that the current price assumes a starting growth rate that is below the recent revenue growth. This means the market is modest about future cash‑flow growth, even as employers keep shifting toward HSAs and FSAs. If the company fails to sustain this growth, the price would be overvalued; if it exceeds expectations, the price could climb further.
The bear case
The weakest pillar in our model is Value 63, reflecting that HQY is only modestly cheap compared to peers. A single adverse event—such as a regulatory change that limits HSA contributions or a shift in employer benefit strategy—could compress the growth trajectory. If revenue growth were to dip below 5 %, the company would struggle to deliver even the modest cash‑flow growth the price implies, and the stock would likely retreat.
What would change our mind
- Revenue growth falling below 5 % YoY would erode the growth pillar and push the valuation toward the lower end of the analyst range.
- Free‑cash‑flow falling below $400 m would signal that the company can no longer sustain its buyback program or invest in platform upgrades, weakening the quality pillar.
- A sharp rise in the PEG ratio without faster expected growth would indicate the price had run ahead of the business, undermining the current thesis that the stock is undervalued.
If any of these thresholds were crossed, the balance would tilt toward the bear case, and the current upside narrative would lose steam.